Charles Schwab’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.63M Buy
3,664,276
+1,017,261
+38% +$730K ﹤0.01% 2591
2025
Q1
$3.89M Buy
2,647,015
+663,775
+33% +$976K ﹤0.01% 2378
2024
Q4
$8.79M Buy
1,983,240
+78,969
+4% +$350K ﹤0.01% 2074
2024
Q3
$7.85M Buy
1,904,271
+364,841
+24% +$1.5M ﹤0.01% 2154
2024
Q2
$10M Buy
1,539,430
+147,027
+11% +$959K ﹤0.01% 2045
2024
Q1
$12.1M Buy
1,392,403
+103,750
+8% +$904K ﹤0.01% 1895
2023
Q4
$14.7M Buy
1,288,653
+57,859
+5% +$662K ﹤0.01% 1778
2023
Q3
$11.9M Sell
1,230,794
-140,974
-10% -$1.36M ﹤0.01% 1824
2023
Q2
$14.6M Sell
1,371,768
-134,923
-9% -$1.44M ﹤0.01% 1703
2023
Q1
$15.9M Buy
1,506,691
+418,419
+38% +$4.4M ﹤0.01% 1631
2022
Q4
$13.5M Buy
1,088,272
+69,334
+7% +$859K ﹤0.01% 1679
2022
Q3
$10.6M Sell
1,018,938
-105,800
-9% -$1.1M ﹤0.01% 1799
2022
Q2
$13M Sell
1,124,738
-303,443
-21% -$3.5M ﹤0.01% 1694
2022
Q1
$18M Sell
1,428,181
-35,310
-2% -$444K 0.01% 1625
2021
Q4
$17.1M Buy
1,463,491
+23,406
+2% +$273K 0.01% 1706
2021
Q3
$18.8M Buy
1,440,085
+258,897
+22% +$3.38M 0.01% 1640
2021
Q2
$15.2M Sell
1,181,188
-8,607
-0.7% -$111K 0.01% 1769
2021
Q1
$13.3M Buy
1,189,795
+35,349
+3% +$395K ﹤0.01% 1790
2020
Q4
$13.2M Buy
1,154,446
+12,465
+1% +$142K 0.01% 1689
2020
Q3
$10.3M Buy
1,141,981
+36,908
+3% +$332K ﹤0.01% 1675
2020
Q2
$11.4M Buy
1,105,073
+119,395
+12% +$1.23M 0.01% 1562
2020
Q1
$9.95M Buy
985,678
+27,524
+3% +$278K 0.01% 1453
2019
Q4
$12.8M Buy
958,154
+22,384
+2% +$298K 0.01% 1517
2019
Q3
$8.03M Buy
935,770
+29,113
+3% +$250K ﹤0.01% 1727
2019
Q2
$9.92M Sell
906,657
-108,690
-11% -$1.19M 0.01% 1597
2019
Q1
$11.5M Buy
1,015,347
+102,499
+11% +$1.16M 0.01% 1498
2018
Q4
$7.92M Sell
912,848
-21,486
-2% -$186K 0.01% 1614
2018
Q3
$14.4M Buy
934,334
+71,603
+8% +$1.11M 0.01% 1378
2018
Q2
$13.8M Buy
862,731
+52,724
+7% +$844K 0.01% 1365
2018
Q1
$10.5M Buy
810,007
+43,316
+6% +$560K 0.01% 1459
2017
Q4
$9.63M Buy
766,691
+3,368
+0.4% +$42.3K 0.01% 1497
2017
Q3
$10.1M Sell
763,323
-3,162
-0.4% -$41.8K 0.01% 1424
2017
Q2
$12.1M Sell
766,485
-34,648
-4% -$548K 0.01% 1214
2017
Q1
$11.4M Buy
801,133
+64,866
+9% +$927K 0.01% 1224
2016
Q4
$9.43M Buy
736,267
+76,315
+12% +$977K 0.01% 1297
2016
Q3
$8.78M Buy
659,952
+139,437
+27% +$1.85M 0.01% 1259
2016
Q2
$5.7M Buy
520,515
+20,942
+4% +$229K 0.01% 1479
2016
Q1
$4.58M Buy
499,573
+10,296
+2% +$94.4K 0.01% 1566
2015
Q4
$4.75M Buy
489,277
+39,738
+9% +$386K 0.01% 1557
2015
Q3
$3.92M Sell
449,539
-22,252
-5% -$194K 0.01% 1624
2015
Q2
$4.77M Buy
471,791
+64,236
+16% +$649K 0.01% 1569
2015
Q1
$5.46M Buy
407,555
+19,346
+5% +$259K 0.01% 1451
2014
Q4
$4.98M Buy
388,209
+13,823
+4% +$177K 0.01% 1455
2014
Q3
$4.06M Buy
374,386
+5,367
+1% +$58.2K 0.01% 1544
2014
Q2
$4.74M Buy
369,019
+18,149
+5% +$233K 0.01% 1439
2014
Q1
$3.62M Buy
350,870
+51,377
+17% +$530K 0.01% 1586
2013
Q4
$2.91M Buy
299,493
+12,224
+4% +$119K 0.01% 1663
2013
Q3
$2.81M Buy
287,269
+21,980
+8% +$215K 0.01% 1628
2013
Q2
$2.28M Buy
+265,289
New +$2.28M 0.01% 1682